ALSO NOTED: Hana BioSciences raises $14.7M;CepTor wins $1.5M milestone; Herceptin wins raves; and much more...

> South San Francisco-based Hana Biosciences has raised $14.7 million through a private placement. Release

> CepTor has pocketed a $1.5 million milestone payment from JCR Pharmaceuticals after the Japanese company filed an Investigational New Drug application for Myodur (C-101) in muscular dystrophy. Release

> Genentech's Herceptin is attracting widespread attention for the remarkable benefits it has demonstrated against breast cancer. Report

> The Senate has approved a bill to stop using Medicare and Medicaid money for Viagra. Article

> Connetics of Palo Alto, CA, has filed a patent infringement lawsuit against Agis Industries in response to Agis' submission of an abbreviated new drug application for a generic version of clobetasol propionate foam. Release

And Finally... The use of sleeping pills by children and very young adults surged 85 percent between 2000 and 2004. Report

Suggested Articles

Tango Therapeutics is ditching its digs in Kendall Square to move into a new building in Boston’s Fenway neighborhood. Third Rock is coming, too.

UPenn scientists found blocking the Wnt/beta-catenin pathway in endothelial cells made chemotherapy more effective in mouse models of glioblastoma.

The Japanese drugmaker pulled the trigger on the deal after getting a look at phase 1 data on the glutenase TAK-062.